Paper Details
- Home
- Paper Details
Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma.
Author: BerkowitzR B, HarrisonJ E, KempJ P, MillerS D, MurrayJ J, NolopK
Original Abstract of the Article :
BACKGROUND: Despite current recommendations, many patients with persistent asthma are still treated with bronchodilators alone. OBJECTIVE: The safety and efficacy of two once daily dosing regimens (200 microg and 400 microg) of mometasone furoate (MF) administered in the morning by using a dry-powd...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1067/mai.2000.109431
データ提供:米国国立医学図書館(NLM)
Mometasone Furoate: A Cooling Breeze in the Desert of Asthma
In the vast desert of respiratory ailments, asthma presents a constant challenge. This research ventures into the therapeutic landscape, exploring the efficacy of mometasone furoate (MF) for treating mild-to-moderate persistent asthma. The study involved a double-blind, randomized controlled trial with 306 participants, comparing the effectiveness of different MF dosing regimens. The primary focus was on the change in forced expiratory volume in one second (FEV1), a key indicator of lung function. The results revealed that a single daily dose of 400 microg MF was as effective as twice-daily administration (200 microg twice daily) in improving FEV1. This finding highlights the potential for convenient, once-daily administration of MF, potentially improving patient adherence to treatment.
A New Oasis in Asthma Management
The research demonstrates that a single daily dose of 400 microg MF, administered through a dry-powder inhaler, can effectively manage mild-to-moderate persistent asthma. This finding is significant because it offers a more convenient and potentially more patient-friendly treatment option. The study also found that all doses of MF were well tolerated, suggesting that it is a safe and effective option for many patients.
Breathing Easy in the Desert of Asthma
This research offers a glimmer of hope for those struggling with asthma, suggesting that a once-daily regimen of MF can be effective. It is important to discuss your individual needs and treatment options with a healthcare professional. Remember, like a traveler in the desert seeking a reliable water source, finding the right treatment for asthma can significantly improve quality of life.
Dr.Camel's Conclusion
This research reminds us that the desert of asthma can be navigated with effective and convenient treatment options. It's a reminder that like a cool breeze in a harsh desert, advancements in medicine can provide much-needed relief.
Date :
- Date Completed 2000-11-08
- Date Revised 2015-11-19
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.